PTJ
NVO

Paul Tudor Jones’s Novo Nordisk NVO Stock Holding History

Paul Tudor Jones’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.74M Sell
182,382
-258,235
-59% -$11.1M 0.01% 901
2026
Q1 		$16.2M Buy
440,617
+206,349
+88% +$9.78M 0.03% 513
2025
Q4 		$11.9M Buy
+234,268
New +$12M 0.02% 631
2025
Q2 		– Sell
-230,073
Closed -$15.6M – 3609
2025
Q1 		$16M Buy
230,073
+108,031
+89% +$8.92M 0.05% 279
2024
Q4 		$10.5M Buy
122,042
+107,815
+758% +$11.7M 0.04% 341
2024
Q3 		$1.69M Buy
+14,227
New +$1.9M 0.01% 1305
2024
Q2 		– Sell
-51,315
Closed -$6.8M – 2647
2024
Q1 		$6.59M Sell
51,315
-161,191
-76% -$19.2M 0.04% 495
2023
Q4 		$22M Buy
212,506
+51,499
+32% +$5.09M 0.18% 104
2023
Q3 		$14.6M Buy
161,007
+108,099
+204% +$9.52M 0.15% 115
2023
Q2 		$4.28M Buy
52,908
+4,516
+9% +$369K 0.05% 501
2023
Q1 		$3.85M Buy
+48,392
New +$3.43M 0.06% 484
2022
Q3 		– Sell
-24,012
Closed -$1.34M – 2583
2022
Q2 		$1.34M Buy
+24,012
New +$1.33M 0.04% 706
2022
Q1 		– Sell
-8,802
Closed -$493K – 2465
2021
Q4 		$493K Buy
+8,802
New +$477K 0.01% 1478

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Paul Tudor Jones's NVO Position: Q2 2026 in Review

Paul Tudor Jones reduced its Novo Nordisk (NVO) stake by 59% in Q2 2026, selling an estimated $11.1M and leaving 182,382 shares worth $8.74M. The position accounts for 0.01% of the portfolio, ranked #901.

Paul Tudor Jones first reported a position in NVO in Q4 2021 and has held it in 13 quarters since. The position peaked at $22M in Q4 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Paul Tudor Jones held 182,382 shares of Novo Nordisk worth $8.74M as of Q2 2026.
  • Paul Tudor Jones sold 258,235 Novo Nordisk shares in Q2 2026, an estimated $11.1M.
  • Novo Nordisk made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #901 holding.
  • Paul Tudor Jones first reported a position in Novo Nordisk in Q4 2021 and has held it in 13 quarters since.
  • Paul Tudor Jones's Novo Nordisk position peaked at $22M in Q4 2023.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.